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Introduction: Safe, effective glycemic control (GC) can improve outcomes, but is difficult to 
achieve consistently. Glycemic level and variability are independently associated with mortality. 
Patho-physiologically, the negative outcomes of dysglycemia are associated with exposure and 
repetition to high glucose levels, indicating that metrics of exposure might accurately capture 
outcome. 
 
Objectives: To determine the cumulative time in band (cTIB) thresholds associated with 
improved outcomes for achieving intermediate levels of GC (4.0-7.0 mmol/L, 5.0-8.0mmol/L and 
4.0-8.0mmol/L). 
 
Method: Retrospective analysis of patient data (N=1717) from the SPRINT (N=784) before-after 
study and the Glucontrol (N=933) randomized clinical trial. cTIB is defined as the percentage of 
blood glucose from start to the present day within the specified band. It is evaluated daily for the 
4.0-7.0mmol/L, 5.0-8.0mmol/L and 4.0-8.0mmol/L bands, with thresholds (t = 50%, 60%, 70%, 
80%) for all patients. The odds ratio (OR) is calculated for cTIB≥t versus cTIB<t, including 95% CI 
for each day 1-14. 
 
Results: The table shows OR range for days 1-14. For all glycemic bands and all thresholds t, 
OR > 1.0 for all days, except day 1.  
 𝑡 = 50% 𝑡 = 60% 𝑡 = 70% 𝑡 = 80% 
4.0-7.0mmol/L band 1.10-1.42 1.07-1.98 1.08-2.35 1.18-3.76 
5.0-8.0mmol/L band 1.14-1.34 0.98-1.65 0.98-2.39 1.07-1.70 
4.0-8.0mmol/L band 1.04-1.28 1.00-1.54 0.96-1.65 0.91-2.28 
 
The lower bound of the 95%CI over days 1-10 where patient data is greatest is: 
 𝑡 = 50% 𝑡 = 60% 𝑡 = 70% 𝑡 = 80% 
4.0-7.0mmol/L band 0.85-0.96 0.82-1.12 0.81-1.56 0.84-1.67 
5.0-8.0mmol/L band 0.89-0.88  0.76-0.89 0.74-1.02 0.78-0.90 
4.0-8.0mmol/L band 0.80-0.82 0.78-0.81 0.74-0.98 0.70-1.10 
 
Conclusion: Results show that for cTIB in the 4.0-7.0mmol/L band high cTIB is associated with 
increasingly lower mortality over days 1-14 and the 95%CI is increasingly above 1.0 over time. 
The 4.0-8.0mmol/L and 5.0-8.0mmol/L bands had significantly reduced benefit and confidence in 
comparison. This suggests that tighter GC positively influences patient outcome if control is 
maintained and exposure to glycemia outside 4.0-7.0mmol/L is limited. cTIB is readily calculated 
and can be used to continuously assess quality of control during a patient’s stay unlike other 
metrics and analyses, which require a full patient stay of data. 
 
 
